Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
<h4>Background</h4>Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations of an inac...
Saved in:
| Main Authors: | Chien-Te Tseng, Elena Sbrana, Naoko Iwata-Yoshikawa, Patrick C Newman, Tania Garron, Robert L Atmar, Clarence J Peters, Robert B Couch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0035421&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection.
by: Tomoki Yoshikawa, et al.
Published: (2010-01-01) -
IMMUNOPATHOLOGY AND IMMUNOPHARMACOTHERAPY OF CORONAVIRUS DISEASE 2019 (COVID-19): FOCUS ON INTERLEUKIN 6
by: E. L. Nasonov
Published: (2020-06-01) -
Developments in the laboratory diagnosis of SARS — coronavirus infections
by: A.A. Hoosen, et al.
Published: (2005-05-01) -
Advancements in the development of antivirals against SARS-Coronavirus
by: Mrityunjay Kumar, et al.
Published: (2025-01-01) -
Characterizing neuroinvasion and neuropathology of SARS-CoV-2 by using AC70 human ACE2 transgenic mice
by: Jason C. Hsu, et al.
Published: (2024-09-01)